Status:
TERMINATED
Behavioral Therapy Development for Methamphetamine Abuse
Lead Sponsor:
University of California, Los Angeles
Conditions:
Depression
Drug Abuse
Eligibility:
MALE
18-65 years
Phase:
PHASE1
Brief Summary
The purpose of this study is to evaluate whether a specially developed group counseling approach is better able to help HIV-positive gay and bisexual men (GBM) who use crystal meth to stop using metha...
Detailed Description
The study features activities that include development and refinement of a culturally-specific cognitive behavioral therapy that integrates aspects of drug abuse treatment with HIV medication adherenc...
Eligibility Criteria
Inclusion
- HIV-seropositive, GBM receiving medical treatment for HIV for at least 30 days prior to signing informed consent at the University of California, Los Angeles (UCLA) Center for Clinical AIDS Research and Education (CARE) clinic, aged 18-65
- Willing to give informed consent and comply with study procedures
- Willing to provide consent to contact treating physicians and pharmacies to assess adherence to HIV medications
- Diagnosed with current methamphetamine abuse as determined by Mini-International Neuropsychiatric Interview (MINI)
- Interested in seeking treatment for methamphetamine abuse and in participating in this research project.
Exclusion
- Unwilling to give, or withdrawal of, informed consent
- Inability to understand nature of study
- A psychiatric condition that, in the principal investigator's judgment, warrants additional intervention to ensure participant safety (e.g., meets Diagnostic and Statistical Manual of Mental Disorders, 4th Edition, Text Revision \[DSM-IV-TR\] criteria for current bipolar disorder or a psychotic disorder)
- Current suicidal ideation or suicide attempt within the past 3 months
- Concurrent dependence on opiates, alcohol, or benzodiazepines as determined by MINI.
- Total lack of any type of healthcare coverage. These potential participants will be given low-fee treatment referrals.
Key Trial Info
Start Date :
August 1 2004
Trial Type :
INTERVENTIONAL
End Date :
November 1 2007
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00252434
Start Date
August 1 2004
End Date
November 1 2007
Last Update
January 27 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UCLA Center for Clinical AIDS Research and Education (CARE) Clinic
Los Angeles, California, United States, 90035